Áreas terapeúticas

This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.

RSV is the primary cause of LRTIs in children worldwide.² Infants aged 3 months old have the highest risk of severe RSV LRTIs.² 

In Singapore, RSV circulates all-year round and causes significant paediatric health and economic burden.² This highlights the need and importance of RSV immunisation to reduce the burden of disease.²

T1D is a chronic, autoimmune disease with a complex, multifactorial etiology. Explore how genetics and environmental factors can trigger autoimmunity

En este estudio, se comparó Hexacima® vs la vacuna hexavalente que requiere reconstitución antes de su administración.